BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37913851)

  • 21. Discovery and SAR of Natural-Product-Inspired RXR Agonists with Heterodimer Selectivity to PPARδ-RXR.
    Nakashima KI; Yamaguchi E; Noritake C; Mitsugi Y; Goto M; Hirai T; Abe N; Sakai E; Oyama M; Itoh A; Inoue M
    ACS Chem Biol; 2020 Jun; 15(6):1526-1534. PubMed ID: 32374156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational Design of a New RXR Agonist Scaffold Enabling Single-Subtype Preference for RXRα, RXRβ, and RXRγ.
    Adouvi G; Isigkeit L; López-García Ú; Chaikuad A; Marschner JA; Schubert-Zsilavecz M; Merk D
    J Med Chem; 2023 Jan; 66(1):333-344. PubMed ID: 36533416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice.
    Yamamoto A; Kakuta H; Sugimoto Y
    Int Immunopharmacol; 2014 Sep; 22(1):204-8. PubMed ID: 24975659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational analysis of the structural basis of ligand binding to the crustacean retinoid X receptor.
    Nagaraju GP; Prasad GL; Taliaferro-Smith L; Aruna BV; Naik BR; Sekhar YN
    Comp Biochem Physiol Part D Genomics Proteomics; 2010 Dec; 5(4):317-24. PubMed ID: 20937572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression.
    Minucci S; Leid M; Toyama R; Saint-Jeannet JP; Peterson VJ; Horn V; Ishmael JE; Bhattacharyya N; Dey A; Dawid IB; Ozato K
    Mol Cell Biol; 1997 Feb; 17(2):644-55. PubMed ID: 9001218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of yeast reporter assay for screening specific ligands of retinoic acid and retinoid X receptor subtypes.
    Shiizaki K; Yoshikawa T; Takada E; Hirose S; Ito-Harashima S; Kawanishi M; Yagi T
    J Pharmacol Toxicol Methods; 2014; 69(3):245-52. PubMed ID: 24530888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos.
    Luria A; Furlow JD
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8987-92. PubMed ID: 15178767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer.
    Tanaka T; Suh KS; Lo AM; De Luca LM
    J Biol Chem; 2007 Oct; 282(41):29987-97. PubMed ID: 17656367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpressed activated retinoid X receptors can mediate growth inhibitory effects of retinoids in human carcinoma cells.
    Wan H; Dawson MI; Hong WK; Lotan R
    J Biol Chem; 1998 Oct; 273(41):26915-22. PubMed ID: 9756939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of lipophilicity at the lipophilic domain of RXR agonists enables production of subtype preference: RXRalpha-preferential agonist possessing a sulfonamide moiety.
    Takamatsu K; Takano A; Yakushiji N; Morishita K; Matsuura N; Makishima M; Ali HI; Akaho E; Tai A; Sasaki K; Kakuta H
    ChemMedChem; 2008 Mar; 3(3):454-60. PubMed ID: 18157857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
    Schierle S; Merk D
    Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
    [No Abstract]   [Full Text] [Related]  

  • 33. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
    Desphande A; Xia G; Boerma LJ; Vines KK; Atigadda VR; Lobo-Ruppert S; Grubbs CJ; Moeinpour FL; Smith CD; Christov K; Brouillette WJ; Muccio DD
    Bioorg Med Chem; 2014 Jan; 22(1):178-85. PubMed ID: 24359708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
    Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Promiscuity of Allosteric Regulation of Nuclear Receptors by Retinoid X Receptor.
    Clark AK; Wilder JH; Grayson AW; Johnson QR; Lindsay RJ; Nellas RB; Fernandez EJ; Shen T
    J Phys Chem B; 2016 Aug; 120(33):8338-45. PubMed ID: 27110634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a novel cardiac-enriched retinoid X receptor partner.
    Cresci S; Clabby ML; Kelly DP
    J Biol Chem; 1999 Sep; 274(36):25668-74. PubMed ID: 10464303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Isochroman Analog of CD3254 and Allyl-, Isochroman-Analogs of NEt-TMN Prove to Be More Potent Retinoid-X-Receptor (RXR) Selective Agonists Than Bexarotene.
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sausedo MA; Moen GA; Lee IJ; Ivan DJ; Krall TD; Peoples SJ; Perez A; Tromba L; Le A; Khadka I; Petros R; Savage BM; Salama E; Salama J; Ziller JW; Noh Y; Lee MY; Liu W; Welch JS; Marshall PA; Wagner CE
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo.
    Lemon BD; Freedman LP
    Mol Cell Biol; 1996 Mar; 16(3):1006-16. PubMed ID: 8622645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance.
    Lu J; Cistola DP; Li E
    Biochemistry; 2006 Feb; 45(6):1629-39. PubMed ID: 16460010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence properties of retinoid X receptor antagonist NEt-SB.
    Yamada S; Takamura Y; Fujihara M; Kawasaki M; Ito S; Nakano S; Kakuta H
    Bioorg Med Chem Lett; 2021 Jan; 31():127666. PubMed ID: 33152377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.